A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Clinical trial NCT04492033 · TERMINATED

Trial details

NCT number: NCT04492033
Sponsor: Handok Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

P1b: Advanced Solid Tumors P2: Biliary Tract Cancer

Start date: 2020-06-22
Primary completion: 2024-01-08
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.